Institutional Ownership
Avadel Pharmaceuticals PLC
CUSIP G29687103COM SHSQ1 2026
13D / 13G Filings
14
Schedule 13D/13G on record
Beneficial Filers
5
Distinct reporting persons
Largest Stake
14.6%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
14 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Janus Henderson Group PLC | 13G/A | 1.9% | 1.82M | SEC |
| 2 | Feb 17, 2026 | Two Seas Capital LP | 13G/A | — | 312.0K | SEC |
| 3 | Feb 12, 2026 | Brandes Investment Partners, LP | 13G/A | 0.2% | 218.8K | SEC |
| 4 | Nov 14, 2025 | Janus Henderson Group PLC | 13G/A | 7.7% | 7.43M | SEC |
| 5 | Aug 14, 2025 | Janus Henderson Group PLC | 13G/A | 11.5% | 11.13M | SEC |
| 6 | Aug 13, 2025 | Two Seas Capital LP | 13G/A | 6.4% | — | SEC |
| 7 | Jul 29, 2025 | The Vanguard Group | 13G | 5.7% | 5.56M | SEC |
| 8 | Jul 29, 2025 | The Vanguard Group | 13G | 5.7% | 5.56M | SEC |
| 9 | Jul 16, 2025 | Blackrock, Inc. | 13G/A | 7.0% | 6.74M | SEC |
| 10 | May 15, 2025 | Two Seas Capital LP | 13G | 5.1% | — | SEC |
4 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Avadel Pharmaceuticals PLC.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ifp Advisors, Inc | 20 | $426 |